logo BDSP

Base documentaire

  1. Fulltext. The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.

    Article - En anglais



    This study examined whether there is a risk that tetanus-toxoid-containing vaccines could cause Guillain-Barré syndrome and, if so, how large the risk is.


    This study was based on previous active surveillance epidemiological studies of Guillain-Barré syndrome and vaccination history.


    A background rate of 0.3 cases of Guillain-Barré syndrome permillion person-weeks has been estimated.

    By chance, 2.2 people with the syndrome would have received tetanus-toxoid-containing vaccine within the 6 weeks before onset, yet only 1 person had done so.

    Data on children show similar results


    If an association exists, it must be extremely rare and not of public health significance.

    Mots-clés Pascal : Polyneuropathie périphérique, Etats Unis, Amérique du Nord, Amérique, Vaccination, Tétanos, Bactériose, Infection, Anatoxine, Risque, Epidémiologie, Incidence, Adulte, Homme, Enfant, Système nerveux pathologie, Nerf périphérique pathologie, Complication

    Mots-clés Pascal anglais : Polyneuropathy, United States, North America, America, Vaccination, Tetanus, Bacteriosis, Infection, Toxoid, Risk, Epidemiology, Incidence, Adult, Human, Child, Nervous system diseases, Peripheral nerve disease, Complication

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0074268

    Code Inist : 002B17F. Création : 14/05/1998.